MDDScore: confirmation of a blood test to aid in the diagnosis of major depressive disorder.

@article{Bilello2015MDDScoreCO,
  title={MDDScore: confirmation of a blood test to aid in the diagnosis of major depressive disorder.},
  author={John A. Bilello and Linda M. Thurmond and Katie M. Smith and Bo Pi and Robert Rubin and Suzin M Wright and Floyd E. Taub and Michael E. Henry and Richard C. Shelton and George I. Papakostas},
  journal={The Journal of clinical psychiatry},
  year={2015},
  volume={76 2},
  pages={
          e199-206
        }
}
BACKGROUND Previously, a biomarker panel was developed for use as an aid to major depressive disorder (MDD) diagnosis; it consisted of 9 biomarkers associated with the neurotrophic, metabolic, inflammatory, and hypothalamic-pituitary-adrenal axis pathways. This panel and associated algorithm produced good clinical sensitivity and specificity (92% and 81%, respectively) in differentiating MDD patients from individuals without MDD. To further validate the panel, we performed a prospective study… Expand
Potential biomarkers of major depression diagnosis and chronicity
TLDR
Results indicate that changes in specific biomarkers have potential on the evaluation of MDD chronicity, but not for its diagnosis. Expand
Major depressive disorder is associated with changes in a cluster of serum and urine biomarkers.
TLDR
An algorithm to combine the heterogeneity at biomarker level enabled the identification of correlating biomarkers based on differences in variation and distribution between groups, combined the outcome of the selected biomarkers, and calculated depression probability scores. Expand
Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder
TLDR
In the future, more sophisticated multiplex assays may hold promise for use in screening and diagnosing depression and determining clinical severity as an advance over relying solely on current subjective diagnostic criteria. Expand
Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells.
TLDR
It is suggested that early disturbances of PBMC energy and neurotransmitter metabolism may be associated with the onset of MDD, and this metabolite signature may facilitate development of a laboratory-based diagnostic test for MDD. Expand
Biomarkers of Depression: Potential Diagnostic Tools
TLDR
There is an unmet need to search for the validated set of different biomarkers or the complex multi-marker panels that might be used to reliably and reproducibly predict and confirm the MDD diagnosis. Expand
Is there Progress ? An Overview of Select Biomarker Candidates for 1 Major Depressive Disorder 2
14 Major Depressive Disorder (MDD) contributes to a significant worldwide disease burden, expected 15 to be second only to heart disease by 2050. However, accurate diagnosis has been a historical 16Expand
Gene expression-based biological test for major depressive disorder: an advanced study
TLDR
This expression panel was able to segregate patients with MDD from those without MDD with a sensitivity and specificity of 64% and 67.9%, respectively, and research to identify MDD-specific markers is needed to improve the performance of this biological test. Expand
Seeking an objective diagnosis of depression.
TLDR
A brief overview evaluates the technical basis for new technologies from genomics, transcriptomics, proteomics, metabolomics and imaging and discusses how the extension of their clinical performance can lead to an objective diagnosis of MDD. Expand
Early warning biomarkers in major depressive disorder: a strategic approach to a testing question
  • R. Pratt, N. Stapelberg
  • Psychology, Medicine
  • Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
  • 2018
TLDR
Development of integrals and differentials of biomarkers that can be used in screening for MDD and planning future biomarker research, targeting intracellular and extracellular inflammation, HPA axis dysfunction, and tryptophan metabolism are targeted. Expand
The Combination of Serum BDNF, Cortisol and IFN-Gamma Can Assist the Diagnosis of Major Depressive Disorder
  • Suzhen Chen, Yuqun Zhang, Yonggui Yuan
  • Medicine
  • Neuropsychiatric disease and treatment
  • 2021
TLDR
Results showed that combining serum BDNF, cortisol and IFN-gamma could aid the diagnosis of MDD, while baseline retardation and psychological anxiety may predict the poor early symptom improvement. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 70 REFERENCES
Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study
TLDR
The results of the present study suggest that this test can differentiate MDD subjects from non-depressed controls with adequate sensitivity and specificity and further research is needed to confirm the performance of the test across various age and ethnic groups, and in different clinical settings. Expand
The diagnosis of depression: current and emerging methods.
TLDR
The technical basis for and clinical performance of various interview-based instruments and methods to diagnosis depression in clinical settings are evaluated. Expand
Clinical Subtypes of Depression Are Associated with Specific Metabolic Parameters and Circadian Endocrine Profiles in Women: The Power Study
TLDR
Pre-menopausal women with various features of MDD exhibit metabolic, endocrine, and BMD features that may be associated with different health consequences. Expand
Obesity and mental disorders in the adult general population.
TLDR
Stronger associations were observed between anxiety disorders and obesity than between mood disorders and Obesity; the association between PTSD and obesity is a novel finding. Expand
Diagnosis of depression by primary care physicians versus a structured diagnostic interview. Understanding discordance.
TLDR
Differentiating levels of disagreement in depressive diagnoses between the primary care physician and research interview is not as frequent as indicated by an undifferentiated false-negative/ false-positive analysis. Expand
Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey.
TLDR
It is suggested that obesity is associated with depression mainly among persons with severe obesity, and Prospective studies will be necessary to clarify the obesity-depression relation but await the identification of potential risk factors for depression in the obese. Expand
Methods to improve diagnostic accuracy in a community mental health setting.
TLDR
Combining structured interviewing with a review of the medical record appears to produce more accurate primary diagnoses and to identify more secondary diagnoses than routine clinical methods. Expand
Meta‐analyses of agreement between diagnoses made from clinical evaluations and standardized diagnostic interviews
TLDR
Findings from SDIs may not fully apply to diagnoses based on clinical evaluations of the sort used in the published studies, and characteristics of both may limit agreement and generalizability from SDI findings to clinical practice. Expand
A new depression scale designed to be sensitive to change.
TLDR
The construction of a depression rating scale designed to be particularly sensitive to treatment effects is described, and its capacity to differentiate between responders and non-responders to antidepressant treatment was better than the HRS, indicating greater sensitivity to change. Expand
Neurocognition in depression: patients on and off medication versus healthy comparison subjects.
TLDR
Although depressed patients have global neurocognitive impairments, deficits in certain cognitive domains are more important than in others and may have a bearing on treatment and outcome. Expand
...
1
2
3
4
5
...